Cetuximab trials for Pancreatic cancer
All Cetuximab trials · All Pancreatic cancer trials
10
Recruiting trials
Phase breakdown
Phase 1 9Phase 2 4
Recruiting trials studying Cetuximab for Pancreatic cancer
- A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
- A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
- A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
- A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
- Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Common questions
How many trials study Cetuximab for Pancreatic cancer?
10 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.